⌕
Alcon · ALC · NYSE
Tenet 59 · Mixed
Compare
$74.11+0.64%At closeTenet 59 · Mixed
$74.11+0.47 (+0.64%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD
$74.08−0.03 (−0.04%)
After hours: Nov 17, 2026, 4:40 PM ET

Alcon (ALC) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● The Motley FoolNov 11, 2026 · 16:58 ET
Alcon: 3 Key Takeaways for Long-Term Investors

Alcon expects full-year net sales growth of approximately 6%. UNITY equipment reached 40% of U.S. teaching hospitals in 2026.…

● Seeking AlphaNov 11, 2026 · 13:59 ET
Alcon Inc. (ALC) Q3 2026 Earnings Call Transcript

Alcon Inc. ( ALC ) Q3 2026 Earnings Call November 11, 2026 8:00 AM EST Company Participants Daniel Cravens - Vice President of Investor Relations David Endicott - CEO & Director Timothy Stonesifer - Senior VP & CFO Confe…

● Zacks Investment ResearchNov 11, 2026 · 13:40 ET
ALC's Q3 Earnings Beat, Revenues Miss, '26 Outlook Narrows, Stock Down

Alcon's Q3 earnings top estimates as sales miss, margins expand and 2026 growth targets narrow; shares slip after the report.…

● ReutersNov 11, 2026 · 05:18 ET
Alcon shares fall as tighter eye-care market outlook raises growth concerns

Alcon shares fall as tighter eye-care market outlook raises growth concerns…

● Zacks Investment ResearchNov 10, 2026 · 19:01 ET
Alcon (ALC) Reports Q3 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Alcon (ALC) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estim…

● Business WireNov 10, 2026 · 16:30 ET
Innovation and Product Launch Momentum Drive Alcon's Third-Quarter 2026 Growth

GENEVA--(BUSINESS WIRE)--Innovation and Product Launch Momentum Drive Alcon's Third-Quarter 2026 Growth.…

● Zacks Investment ResearchNov 5, 2026 · 10:16 ET
Countdown to Alcon (ALC) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Beyond analysts' top-and-bottom-line estimates for Alcon (ALC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2026.…

● Zacks Investment ResearchNov 5, 2026 · 08:51 ET
Alcon (ALC) Surges 6.8%: Is This an Indication of Further Gains?

Alcon (ALC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.…

● Seeking AlphaOct 21, 2026 · 11:46 ET
Alcon Sees Another Bullish Rating After Clear Portfolio Growth Direction In Eyecare

Alcon Inc. remains a Buy, supported by FDA approvals, portfolio-expanding acquisitions, and robust long-term eyecare demand despite recent market underperformance. ALC demonstrates steady revenue growth, improved core EP…

● Business WireOct 20, 2026 · 16:35 ETCOMPANY'S OWN WORDS
Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2

GENEVA--(BUSINESS WIRE)--Alcon Acquires Neurotech and ENCELTO, the Only FDA Approved Treatment for MacTel Type 2.…

● Business WireOct 16, 2026 · 16:38 ET
FDA Approves Alcon's BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes

GENEVA--(BUSINESS WIRE)--FDA Approves Alcon's BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes.…

● Zacks Investment ResearchOct 13, 2026 · 11:25 ET
Credo Expands AI Connectivity Portfolio With 1.6T ZeroFlap ALC

CRDO expands its AI connectivity portfolio with the 1.6T ZeroFlap Active Light Cable, offering lower power consumption, enhanced reliability and extended reach.…

● Zacks Investment ResearchSep 4, 2026 · 08:55 ET
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?

Alcon's acquisitions, partnerships and new product launches support growth, but tariffs and intense competition remain key risks.…

● Seeking AlphaSep 3, 2026 · 09:07 ET
Alcon: A Re-Rating In Eyesight

Alcon is a structurally advantaged ophthalmology leader with a durable equipment-to-consumables model and strong recurring revenue streams. At $72, ALC trades at ~18x forward earnings, reflecting mid-teens EPS growth but…

● Business WireSep 3, 2026 · 09:00 ETCOMPANY'S OWN WORDS
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control

GENEVA--(BUSINESS WIRE)--Alcon Launches UNITY® M, a Premium Ophthalmic Microscope Delivering Precise Control.…

● Business WireAug 26, 2026 · 17:00 ETCOMPANY'S OWN WORDS
Alcon Prices EUR 500 Million Senior Notes Offering

GENEVA--(BUSINESS WIRE)--Alcon Prices EUR 500 Million Senior Notes Offering.…

● Seeking AlphaAug 17, 2026 · 06:10 ET
Alcon: A Strong Company Trading Close To Its Intrinsic Value, Buy

Alcon reported strong core operating profit (barring a one-time non-cash $402 million charge) during the quarter, up 17%. The company raised its full-year 2026 profit forecast for the second consecutive quarter. My DCF v…

Kept in their own lane. A press release is the company talking, not reporting.

No upcoming events in the feeds.

NVDA35−0.4%
ABR4−2.6%
INTC4−0.5%
LAW4−8.6%

Article counts from the last market-wide feed page, across every symbol we track and not just ALC · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.